| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2023 | Apr 6, 2023 | T2 Biosystems, Inc. | General Counsel | Sell | 42.5 | -239 | -3.49% | ✓ | $115 |
| Feb 20, 2023 | Mar 9, 2023 | T2 Biosystems, Inc. | General Counsel | Sell | 20.0 | -3,730 | -24.17% | ✓ | $2.3K |
| Apr 7, 2022 | Apr 11, 2022 | T2 Biosystems, Inc. | General Counsel | Buy | 85.0 | +10,000 | 6.38% | ✗ | $4.9K |
| Mar 24, 2022 | Mar 28, 2022 | T2 Biosystems, Inc. | General Counsel | Sell | 47.5 | -8,790 | -5.31% | ✗ | $3.9K |
| Feb 24, 2022 | Mar 28, 2022 | T2 Biosystems, Inc. | General Counsel | Sell | 46.3 | -76,867 | -34.07% | ✗ | $34.5K |
| Feb 21, 2022 | Mar 28, 2022 | T2 Biosystems, Inc. | General Counsel | Sell | 47.5 | -5,275 | -6.19% | ✗ | $2.5K |
| Feb 24, 2022 | Feb 28, 2022 | T2 Biosystems, Inc. | General Counsel | Sell | 46.3 | -76,867 | -35.65% | ✗ | $34.5K |
| Feb 21, 2022 | Feb 23, 2022 | T2 Biosystems, Inc. | General Counsel | Sell | 47.5 | -5,275 | -7.01% | ✗ | $2.5K |
| Mar 24, 2021 | Mar 25, 2021 | T2 Biosystems, Inc. | General Counsel | Sell | 28.8 | -8,758 | -10.68% | ✓ | $13.7K |
| Feb 21, 2021 | Feb 23, 2021 | T2 Biosystems, Inc. | General Counsel | Sell | 28.8 | -7,280 | -10.02% | ✓ | $15K |
| Feb 21, 2020 | Feb 25, 2020 | T2 Biosystems, Inc. | General Counsel | Sell | 33.8 | -5,808 | -8.72% | ✓ | $4.8K |
| Feb 9, 2020 | Feb 12, 2020 | T2 Biosystems, Inc. | General Counsel | Sell | 37.5 | -3,200 | -5.35% | ✓ | $2.5K |
| Feb 3, 2020 | Feb 5, 2020 | T2 Biosystems, Inc. | General Counsel | Sell | 37.5 | -3,283 | -5.74% | ✓ | $2.9K |
| Feb 9, 2019 | Feb 12, 2019 | T2 Biosystems, Inc. | General Counsel | Sell | 41.3 | -3,005 | -4.99% | ✓ | $10.1K |
| Nov 30, 2017 | Feb 5, 2019 | T2 Biosystems, Inc. | General Counsel | Sell | 27.5 | -2,759 | -4.82% | ✗ | $9.5K |
| Jul 20, 2018 | Jul 24, 2018 | T2 Biosystems, Inc. | General Counsel | Sell | 22.5 | -7,824 | -15.40% | ✗ | $52.6K |
| Feb 9, 2018 | Jun 8, 2018 | T2 Biosystems, Inc. | General Counsel | Sell | 91.3 | +7,592 | 39.72% | ✗ | $49.6K |
| Jun 6, 2017 | Jun 8, 2017 | T2 Biosystems, Inc. | General Counsel | Buy | 90.0 | +1,000 | 10.60% | ✗ | $3.5K |